17:13 EDT Benitec Biopharma (BNTC) files to sell 900K shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTC:
- Positive Buy Recommendation for Benitec Biopharma Driven by Promising Clinical Progress and Strong Financial Position
- Benitec Biopharma reports Q3 EPS (24c) vs. (23c) last year
- Benitec Biopharma price target raised to $20 from $18 at Citizens JMP
- Promising Clinical Results and Financial Stability Drive Buy Rating for Benitec Biopharma
- new option listings on April 9th